Delhi, Bangkok Blasts

  • Most Popular
  • Most Shared

Reuters Showcase

Sensex above 18K

Sensex above 18K

The benchmark breaches the 18,000 mark as automaker and banking shares rise.  Quote 

Snag in Talks

Snag in Talks

Yahoo-Alibaba talks at an impasse - sources.  Full Article 

Euro Debt Crisis

Euro Debt Crisis

China to keep investing in euro zone debt - central bank governor.  Full Article 

iPad Trouble

iPad Trouble

Apple may face iPad export ban in China trademark row.  Full Article | Related Story 

Buy, Sell or Hold?

Buy, Sell or Hold?

Stock recommendations from VantageTrade.  Full Coverage 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage 

Panacea Biotec signs swine flu vaccine pact

Stocks

   

MUMBAI, March 3 | Wed Mar 3, 2010 1:58pm IST

MUMBAI, March 3 (Reuters) - Panacea Biotec (PNCA.BO) said on Wednesday it has signed an advance market agreement with the Government of India to manufacture Pandyflu, the firm's swine flu vaccine.

The company , which has set up a manufacturing unit in Punjab for the vaccine, will have an annual capacity of 45 million doses, it said in a statement.

The firm also said it expects the vaccine to be available by April 2010 for emrgency use, it added.

(Reporting by Nandita Bose; Editing by Prem Udayabhanu)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.